Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis

References

• Colombo E., Banki K., Tatum A. H., Daucher J., Ferrante P., Murray R. S., et al. Comparative analysis of antibody and cell‐mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 1997; 99: 1238–50
   PubMedGoogle Scholar
• Banki K., Colombo E., Sia F., Halladay D., Mattson D. H., Tatum A. H., et al. Oligodendrocyte‐specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med 1994; 180: 1649–63
   PubMed Web of Science ®Google Scholar
• van Noort J. M., van Sechel A. C., Bajramovic J. J., el Ouagmiri M., Polman C. H., Lassmann H., et al. The small heat‐shock protein alpha B‐crystallin as candidate autoantigen in multiple sclerosis. Nature 1995; 375: 798–801
   PubMed Web of Science ®Google Scholar
• Walsh M. J., Murray J. M. Dual implication of 2′,3′‐cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement‐binding protein in the pathogenesis of multiple sclerosis. J Clin Invest 1998; 101: 1923–31
   PubMed Web of Science ®Google Scholar
• Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003; 349: 139–45
   PubMed Web of Science ®Google Scholar
• Mayo I., Arribas J., Villoslada P., Alvarez D. R., Rodriguez‐Vilarino S., Montalban X., et al. The proteasome is a major autoantigen in multiple sclerosis. Brain 2002; 125: 2658–67
   PubMed Web of Science ®Google Scholar
• Orlowski M., Wilk S. A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptide. Biochem Biophys Res Commun 1981; 101: 814–22
   PubMed Web of Science ®Google Scholar
• Tanaka K., Yoshimura T., Kumatori A., Ichihara A., Ikai A., Nishigai M., et al. Proteasomes (multi‐protease complexes) as 20 S ring‐shaped particles in a variety of eukaryotic cells. J Biol Chem 1988; 263: 16209–17
   PubMed Web of Science ®Google Scholar
• Hershko A. Roles of ubiquitin‐mediated proteolysis in cell cycle control. Curr Opin Cell Biol 1997; 9: 788–99
   PubMed Web of Science ®Google Scholar
• Glickman M. H., Ciechanover A. The ubiquitin‐proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373–428
   PubMed Web of Science ®Google Scholar
• Jourd'heuil D., Morise Z., Conner E. M., Kurose I., Grisham M. B. Oxidant‐regulation of gene expression in the chronically inflamed intestine. Keio J Med 1997; 46: 10–15
   PubMedGoogle Scholar
• Palombella V. J., Rando O. J., Goldberg A. L., Maniatis T. The ubiquitin‐proteasome pathway is required for processing the NF‐kappa B1 precursor protein and the activation of NF‐kappa B. Cell 1994; 78: 773–85
   PubMed Web of Science ®Google Scholar
• Schwechheimer C. The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim Biophys Acta 2004; 1695: 45–54
   PubMed Web of Science ®Google Scholar
• Kloetzel P. M. The proteasome and MHC class I antigen processing. Biochim Biophys Acta 2004; 1695: 225–33
   PubMed Web of Science ®Google Scholar
• Wolf D. H., Hilt W. The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 2004; 1695: 19–31
   PubMed Web of Science ®Google Scholar
• Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994; 78: 761–71
   PubMed Web of Science ®Google Scholar
• Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31
   PubMed Web of Science ®Google Scholar
• Polman C. H., Reingold S. C., Edan G., Filippi M., Hartung H. P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 2005; 58: 840–6
   PubMed Web of Science ®Google Scholar
• McDonald W. I., Compston A., Edan G., Goodkin D., Hartung H. P., Lublin F. D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121–7
   PubMed Web of Science ®Google Scholar
• Ghezzi A., Martinelli V., Torri V., Zaffaroni M., Rodegher M., Comi G., et al. Long‐term follow‐up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J Neurol 1999; 246: 770–5
   PubMed Web of Science ®Google Scholar
• Celesia G. G., Kaufman D. I., Brigell M., Toleikis S., Kokinakis D., Lorance R., et al. Optic neuritis: a prospective study. Neurology 1990; 40: 919–23
   PubMed Web of Science ®Google Scholar
• Frederiksen J. L., Larsson H. B., Olesen J., Stigsby B. MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 1991; 83: 343–50
   PubMed Web of Science ®Google Scholar
• Hendil K. B., Uerkvitz W. The human multicatalytic proteinase: affinity purification using a monoclonal antibody. J Biochem Biophys Methods 1991; 22: 159–65
   PubMedGoogle Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
   PubMed Web of Science ®Google Scholar
• Studier F. W. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol 1973; 79: 237–48
   PubMed Web of Science ®Google Scholar
• Kristensen P., Johnsen A. H., Uerkvitz W., Tanaka K., Hendil K. B. Human proteasome subunits from 2‐dimensional gels identified by partial sequencing. Biochem Biophys Res Commun 1994; 205: 1785–9
   PubMedGoogle Scholar
• Sorensen B. K., Hojrup P., Ostergard E., Jorgensen C. S., Enghild J., Ryder L. R., et al. Silver staining of proteins on electroblotting membranes and intensification of silver staining of proteins separated by polyacrylamide gel electrophoresis. Anal Biochem 2002; 304: 33–41
   PubMed Web of Science ®Google Scholar
• Teunissen C. E., Dijkstra C., Polman C. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 2005; 4: 32–41
   PubMed Web of Science ®Google Scholar
• McLean B. N., Luxton R. W., Thompson E. J. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG‐Index. A comparison and diagnostic applications. Brain 1990; 113((Pt 5))1269–89
   PubMedGoogle Scholar
• Bartosik‐Psujek H., Archelos J. Tau protein and 14‐3‐3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. J Neurol 2004; 251: 414–20
   PubMed Web of Science ®Google Scholar
• Bagnato F., Durastanti V., Finamore L., Volante G., Millefiorini E. Beta‐2 microglobulin and neopterin as markers of disease activity in multiple sclerosis. Neurol Sci 2003; V24: s301–4
   Google Scholar
• Arribas J., Luz R. M., Alvarez‐Do F. R., Castano J. G. Autoantibodies against the multicatalytic proteinase in patients with systemic lupus erythematosus. J Exp Med 1991; 173: 423–7
   PubMed Web of Science ®Google Scholar
• Feist E., Kuckelkorn U., Dorner T., Donitz H., Scheffler S., Hiepe F., et al. Autoantibodies in primary Sjogren's syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 1999; 42: 697–702
   PubMed Web of Science ®Google Scholar
• Feist E., Dorner T., Kuckelkorn U., Scheffler S., Burmester G., Kloetzel P. Diagnostic importance of anti‐proteasome antibodies. Int Arch Allergy Immunol 2000; 123: 92–7
   PubMed Web of Science ®Google Scholar
• Stenager E., Moller R., Bronnum‐Hansen H., Koch‐Henriksen N. J. [Multiple sclerosis: its change in prevalence in Denmark, 1950–1996, and its total prevalence in Danish counties in 1996]. Ugeskr Laeger 2005; 167: 1500–2
   PubMedGoogle Scholar
• Koch‐Henriksen N., Rasmussen S., Stenager E., Madsen M. The Danish Multiple Sclerosis Registry. History, data collection and validity. Dan Med Bull 2001; 48: 91–4
   PubMed Web of Science ®Google Scholar